WELLS FARGO & COMPANY/MN - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$259,000
+3.2%
177,515
+0.6%
0.00%
Q4 2016$251,000
+55.9%
176,465
+91.6%
0.00%
Q3 2016$161,0000.0%92,104
-2.2%
0.00%
Q2 2016$161,000
-23.7%
94,136
-12.0%
0.00%
Q1 2016$211,000
+2.9%
107,005
-0.9%
0.00%
Q4 2015$205,000
-13.1%
107,984
-12.8%
0.00%
Q3 2015$236,000
-58.3%
123,816
+1.5%
0.00%
Q2 2015$566,000
+16.0%
122,021
+9.8%
0.00%
Q1 2015$488,000
+373.8%
111,152
+86.0%
0.00%
Q4 2014$103,000
-42.8%
59,744
+39.4%
0.00%
Q3 2014$180,000
-43.9%
42,863
-22.0%
0.00%
Q2 2014$321,000
+50.0%
54,973
+61.4%
0.00%
Q1 2014$214,000
-31.6%
34,069
-37.4%
0.00%
Q4 2013$313,000
+36.7%
54,419
+25.1%
0.00%
Q3 2013$229,000
-40.7%
43,515
-13.3%
0.00%
Q2 2013$386,00050,1650.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 867,700$3,636,0001.05%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,847,999$24,503,0000.89%
MANGROVE PARTNERS IM, LLC 210,900$884,0000.26%
Lyons Wealth Management, LLC. 56,775$238,0000.25%
Callan Capital, LLC 76,118$319,0000.09%
SABBY MANAGEMENT, LLC 274,782$1,151,0000.04%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 338,703$1,420,0000.04%
WELLINGTON MANAGEMENT GROUP LLP 29,627,959$124,141,0000.03%
Cambridge Investment Research Advisors, Inc. 268,118$1,123,0000.03%
OppenheimerFunds, Inc. 7,000,000$29,330,0000.03%
View complete list of ARENA PHARMACEUTICALS INC shareholders